These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 12045044)

  • 1. Infrequent confirmation of visual field progression.
    Lee AC; Sample PA; Blumenthal EZ; Berry C; Zangwill L; Weinreb RN
    Ophthalmology; 2002 Jun; 109(6):1059-65. PubMed ID: 12045044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of visual field progression criteria of 3 major glaucoma trials in early manifest glaucoma trial patients.
    Heijl A; Bengtsson B; Chauhan BC; Lieberman MF; Cunliffe I; Hyman L; Leske MC
    Ophthalmology; 2008 Sep; 115(9):1557-65. PubMed ID: 18378317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glaucoma monitoring in a clinical setting: glaucoma progression analysis vs nonparametric progression analysis in the Groningen Longitudinal Glaucoma Study.
    Wesselink C; Heeg GP; Jansonius NM
    Arch Ophthalmol; 2009 Mar; 127(3):270-4. PubMed ID: 19273789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of glaucoma progression by perimetry and optic disc photography at different stages of the disease: results from the Early Manifest Glaucoma Trial.
    Öhnell H; Heijl A; Anderson H; Bengtsson B
    Acta Ophthalmol; 2017 May; 95(3):281-287. PubMed ID: 27778463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining progressive visual field loss in serial Humphrey visual fields.
    Birch MK; Wishart PK; O'Donnell NP
    Ophthalmology; 1995 Aug; 102(8):1227-34; discussion 1234-5. PubMed ID: 9097752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of visual field progression between eyes in patients with open-angle glaucoma.
    Chen PP
    Ophthalmology; 2002 Nov; 109(11):2093-9. PubMed ID: 12414421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agreement and Predictors of Discordance of 6 Visual Field Progression Algorithms.
    Saeedi OJ; Elze T; D'Acunto L; Swamy R; Hegde V; Gupta S; Venjara A; Tsai J; Myers JS; Wellik SR; De Moraes CG; Pasquale LR; Shen LQ; Boland MV
    Ophthalmology; 2019 Jun; 126(6):822-828. PubMed ID: 30731101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selecting visual field tests and assessing visual field deterioration in glaucoma.
    Nouri-Mahdavi K
    Can J Ophthalmol; 2014 Dec; 49(6):497-505. PubMed ID: 25433738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated perimetry: a report by the American Academy of Ophthalmology.
    Delgado MF; Nguyen NT; Cox TA; Singh K; Lee DA; Dueker DK; Fechtner RD; Juzych MS; Lin SC; Netland PA; Pastor SA; Schuman JS; Samples JR;
    Ophthalmology; 2002 Dec; 109(12):2362-74. PubMed ID: 12466186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short wavelength automated perimetry, frequency doubling technology perimetry, and pattern electroretinography for prediction of progressive glaucomatous standard visual field defects.
    Bayer AU; Erb C
    Ophthalmology; 2002 May; 109(5):1009-17. PubMed ID: 11986111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of visual field loss in untreated glaucoma patients and glaucoma suspects in St. Lucia, West Indies.
    Wilson MR; Kosoko O; Cowan CL; Sample PA; Johnson CA; Haynatzki G; Enger C; Crandall D
    Am J Ophthalmol; 2002 Sep; 134(3):399-405. PubMed ID: 12208252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methodological variations in estimating apparent progressive visual field loss in clinical trials of glaucoma treatment.
    Katz J; Congdon N; Friedman DS
    Arch Ophthalmol; 1999 Sep; 117(9):1137-42. PubMed ID: 10496384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of functional visual field loss by automated static perimetry.
    Frisén L
    Acta Ophthalmol; 2014 Dec; 92(8):805-9. PubMed ID: 24698019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Manifest Glaucoma Trial: design and baseline data.
    Leske MC; Heijl A; Hyman L; Bengtsson B
    Ophthalmology; 1999 Nov; 106(11):2144-53. PubMed ID: 10571351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new index to monitor central visual field progression in glaucoma.
    de Moraes CG; Furlanetto RL; Ritch R; Liebmann JM
    Ophthalmology; 2014 Aug; 121(8):1531-8. PubMed ID: 24726202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for visual field progression in treated glaucoma.
    De Moraes CG; Juthani VJ; Liebmann JM; Teng CC; Tello C; Susanna R; Ritch R
    Arch Ophthalmol; 2011 May; 129(5):562-8. PubMed ID: 21555607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Advanced Glaucoma Intervention Study (AGIS): 14. Distinguishing progression of glaucoma from visual field fluctuations.
    Kim J; Dally LG; Ederer F; Gaasterland DE; VanVeldhuisen PC; Blackwell B; Sullivan EK; Prum B; Shafranov G; Beck A; Spaeth GL;
    Ophthalmology; 2004 Nov; 111(11):2109-16. PubMed ID: 15522379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of methods to predict visual field progression in glaucoma.
    Nouri-Mahdavi K; Hoffman D; Ralli M; Caprioli J
    Arch Ophthalmol; 2007 Sep; 125(9):1176-81. PubMed ID: 17846355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and function evaluation (SAFE): I. criteria for glaucomatous visual field loss using standard automated perimetry (SAP) and short wavelength automated perimetry (SWAP).
    Johnson CA; Sample PA; Cioffi GA; Liebmann JR; Weinreb RN
    Am J Ophthalmol; 2002 Aug; 134(2):177-85. PubMed ID: 12140023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of Visual Field Progression in Glaucoma Patients with Progressive Retinal Nerve Fiber Layer Thinning: A 5-Year Prospective Study.
    Yu M; Lin C; Weinreb RN; Lai G; Chiu V; Leung CK
    Ophthalmology; 2016 Jun; 123(6):1201-10. PubMed ID: 27001534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.